CHMP Issues Positive Opinion For Merck���s VICTRELISTM (boceprevir), Oral Hepatitis C Virus (HCV) Protease Inhibitor

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...